platoseedplatoseed
Simple tests for complex diseases.
We make precision diagnostics more accessible, starting with breast cancer prognosis. Current tests that guide the use of therapy are really slow and expensive because they need to be run in complex centralized facilities. Our tests are designed to be easily run by local hospital labs, reducing turnaround time from over three weeks to a few days and for a fraction of the price.
Co-founder, CSO, and PCRchitect at Signatur Biosciences. I teach machine learning to molecules to expand the range of diseases we can diagnose with PCR. NIH F32 Postdoctoral Fellow in the the Stevens Group at Imperial College London; PhD Bioengineering from University of Maryland, College Park; BSc Physics and Cell & Molecular Biology from Seattle University. When I’m not programming DNA, I’m cooking, running, or doing martial arts (Danzan-Ryu Japanese Jujitsu).
Co-founder and CEO of Signatur Biosciences. Startups since the age of 14. First patent at 15. WIPO Best Young Inventor 2010. Twice TEDx speaker. Co-founded Young Change Maker, a social startup that highlights inspiring individuals. Co-founded and sold a company called Sauna en Bois. Bio-engineering from Imperial College London. When I don't work, I race motorcycles, climb or ski. My life-long goal is to develop biotech companies that address global issues.
We expand PCR testing to a whole new range of diseases!
Signatur Biosciences designs smart PCR kits that expand PCR testing to complex diseases by processing multiple biomarkers in a single reaction, enabling integration with standard qPCR machines for broad clinical use. They partner with diagnostics companies and are building an internal test portfolio to tackle biomarker-based disease detection and monitoring.
From the original launch (Jul 2022) — may be outdated.
The smart testing platform that unlocks digital health at home.
Pioneering Breast Cancer Diagnostics for a Healthier Tomorrow
